Abstract: Devices, systems, and methods are disclosed for identifying a driver within a vehicle using short range wireless communication in order to ticket or alert the driver in response to a traffic infraction by the driver. In exemplary embodiments, a short range wireless communication device registers drivers of vehicles at a certain location. The registration captures a unique identifier for each driver at the location from the driver's wireless communication device. When a vehicle commits a traffic infraction, the unique identifier is used to reference a database to determine the identity and address of the driver. The driver may then be sent a notification of the infraction as well as payment options. This notification may be sent directly to the wireless communication device of the driver. In embodiments of the present invention, a smart vehicle acts as a proxy to capture the unique identifier from the driver's wireless communication device and communicates with the short range wireless communication device.

Abstract: Devices, systems and methods are disclosed which relate to implementing location-based quality of service (QoS) for applications running over a mobile communications network. A user sets up one or more “geofenced area(s)” delimited by position coordinates and associated with their mobile computing device. Also associated with each geofenced area is a “QoS Profile” listing a plurality of requested QoS attributes for traffic going to/from the user's mobile computing device or specific applications running on his/her mobile computing device over the mobile communications network. When the user enters a particular geofenced area associated with their mobile computing device, the QoS Profile associated with that geofenced area is loaded as the active QoS Profile for the mobile computing device. Additionally, as part of their QoS Profiles, a user optionally sets up other conditions which trigger changes in requested QoS attributes for their traffic over the mobile communications network.

Abstract: Devices, systems and methods are disclosed which relate to automatically detecting user dissatisfaction and billing a user accordingly. Systems for providing customer service to a user of a telecommunication network include a mobile communication device having logic for submitting a QoS complaint. A billing server on the telecommunications network retrieves a Service Level Agreement (SLA) for the user from a user account database. The billing server also communicates with a CDR database having CDRs associated with the SLAs. Some of the CDRs include QoS complaints from the user. A logic on the billing server references the CDRs. If the billing server determines that a user is not receiving the QoS that is defined in the SLA, then the billing server calculates a discount to apply to the relevant bill.

Abstract: Devices, systems, and methods are disclosed for altering permitted settings of a vehicle according to a driver identified through short range wireless communication. The vehicle captures a unique identifier from a wireless communication device of the driver of the vehicle. This unique identifier is used to reference a database to determine the identity of the driver as well as settings for the driver created by a controlling authority. The controlling authority may be, for instance, a parent or employer of the driver. The settings may limit certain devices within the vehicle and/or the vehicle itself. Speed control settings, radio settings, wireless communication device settings, and various other settings are all possible to limit distractions to the driver. Further, the settings may be influenced by the number or identities of passengers within the vehicle.

Abstract: Devices, systems, and methods are disclosed for identifying a driver versus a passenger within a smart vehicle. This involves a determination of the relative positions of the wireless communication devices within the smart vehicle using near-field communication (NFC) or GPS, AGPS, etc. The wireless communication device detected closest to the driver seat is assumed to be the device owned by the driver. Once identified, the driver can be billed for tolls and other road services, based on the location of the smart vehicle. For instance, as the smart vehicle approaches a toll, a notification can be sent to all of the wireless communication devices. A response from a particular wireless communication device will result in the corresponding user's account being billed for the toll. Further, the smart vehicle can communicate with near-field transceivers placed, for instance, alongside a High-Occupancy Vehicle (HOV) lane.

Abstract: Devices, systems and methods are disclosed which authorize applications to access location-determining technologies on user devices and on service provider networks. An A-GPS agent resident on the device acts as an interface between applications requesting access to the user's location from the A-GPS chipset and helps to coordinate connections between the A-GPS chipset and the Assistance Server. Introduced into the network maintained by the service provider is a verification server running an application identification engine which determines if the request for preliminary location information engendered by the requesting application is approved.

Abstract: A mobile communication device is disclosed which receives a Base Station Transceiver (BTS) broadcast that identifies the serving cell coordinates, PLMN information, etc. The device determines an approximate location in Europe, and uses this information to invoke an almanac containing information about GALILEO satellites rather than GPS satellites. Consequently, broadcast network identifiers are used to determine an appropriate satellite constellation.

Abstract: Devices, systems and methods are disclosed which relate to billing users of a telecommunication network. A billing server is in communication with a geo-fence database. The geo-fence database contains a plurality of geo-fences. Some geo-fences are associated with a single mobile communication devices, such as a home geo-fence, work geo-fence, etc., while other geo-fences are global, such as a stadium geo-fence, toll geo-fence, etc. When a mobile communication device enters the perimeter of a geo-fence, a billing server changes the billing rate at which connections are billed to the user account or bills another user account. The mobile communication device may send a ticket code to the billing server for a reduced billing rate while within a geo-fence. If a mobile communication device enters a toll geo-fence, then the billing server charges the user account for the toll.

Abstract: System(s) and method(s) are provided for a femto cell service framework for registration, activation, and provisioning of femtocell service. An account management service enables femtocell account creation, and registration thereof. Registration includes validation of wireless coverage for a location of operation of a femto AP, and validation of availability enhanced 911 (E911) service. As part of registration provisioning, record(s) are updated to indicate registration status. Connection of femto AP to a network interface triggers activation process; the femto AP delivers an activation request. A femto network validates registration of the connected femto AP and conducts a location tolerance check of a received actual location of the femto AP and a registered location. Upon tolerance validation, a cell identifier and radio frequency channel(s) are assigned to femto AP. When femto AP radiates wireless signal, network activation status indicators are provisioned.

Abstract: System(s) and method(s) are provided for a femto cell service framework for purchase of femtocell equipment and service and customer support thereof. A point of sale (POS) platform enables purchase of femtocell equipment based on a set of eligibility criteria. POS also allows purchase of add-on services. Direct fulfillment and post-sale transactions such as returns and equipment replacement are also provided. An account management service enables femtocell equipment and service self-care or through customer representatives. Configuration of service account and monitoring of account status is provided. Customer care architecture also enables remote troubleshooting of purchased equipment. Remote troubleshooting includes diagnosis and related manipulation of purchased equipment.

Abstract: Novel parathyroid hormone (PTH) peptides and analogs thereof of the PTH(1-34) fragment are disclosed that combine the N-terminal signaling domain (residues 1-9) and the C-terminal binding domain (residues 15-31) via a linker. Nucleic acid molecules and peptides for PTH(1-9)-(Gly)5-PTH(15-31) (PG5) and PTH(1-9)-(Gly)7-PTH(15-31) and a novel PTH receptor are disclosed. Additionally, methods of screening for PTH agonists, pharmaceutical compositions and methods of treatment are disclosed.

Abstract: The invention provides a novel PTH receptor polypeptide, r?Nt, characterized by a deletion of the extracellular amino-terminus, ligand binding domain of the receptor. Additionally disclosed are nucleic acid molecules encoding the receptor. The receptor has a minimal domain for ligand binding and is useful in screening assays designed for the identification of agonists and antagonists of PTH receptor activity.

Abstract: Novel parathyroid hormone peptide (PTH) and parathyroid hormone related peptide (PTHrP) or derivatives thereof which are biologically active are disclosed, as are pharmaceutical compositions containing such peptides, and synthetic and recombinant methods for producing such peptides. Also disclosed are methods for treating mammalian conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions containing such peptides. Also disclosed are methods for screening candidate compounds of the invention for antagonistic or agonistic effects on parathyroid hormone receptor action. Also disclosed are diagnostic and therapeutic methods of such compounds.

Abstract: The present invention relates to methods of treatment of mammalian conditions characterized by decreases in bone mass with conformationally constrained parathyroid hormone (PTH) analogs and derivatives of those analogs containing PTH polypeptide derivatives containing at least one Glu or Lys substitution at position 6 and/or 10, some with installed lactam bridges between the side chains of Lys and Glu. The invention provides derivatives of PTH (1-34), PTH(1-33), PTH(1-32), PTH(1-31), PTH(1-30), PTH(1-29), PTH(1-28), PTH(1-27), PTH(1-26), PTH(1-25), PTH(1-24), PTH(1-23), PTH(1-22), PTH (1-21), PTH(1-20), PTH(1-19), PTH(1-18), PTH(1-17), PTH(1-16), PTH(1-15), PTH(1-14), PTH(1-13), PTH(1-12), PTH(1-11), PTH(1-10) and PTH(1-9) polypeptide. The invention also provides methods of preparing the PTH analogs. Further, the invention encompasses treating conditions that are characterized by undesired bone loss or by the need for bone growth, e.g.

Abstract: Novel parathyroid hormone (PTH) peptides and analogs thereof of the PTH(1-34) fragment are disclosed that combine the N-terminal signaling domain (residues 1-9) and the C-terminal binding domain (residues 15-31) via a linker. Nucleic acid molecules and peptides for PTH(1-9)-(Gly)5-PTH(15-31) (PG5) and PTH(1-9)-(Gly)7-PTH(15-31) and a novel PTH receptor are disclosed. Additionally, methods of screening for PTH agonists, pharmaceutical compositions and methods of treatment are disclosed.

Abstract: Methods of fabricating optical elements that are encapsulated in monolithic matrices. The present invention is based, at least in one aspect, upon the concept of using multiphoton, multi-step photocuring to fabricate encapsulated optical element(s) within a body of a photopolymerizable composition. Imagewise, multi-photon polymerization techniques are used to form the optical element. The body surrounding the optical element is also photohardened by blanket irradiation and/or thermal curing to help form an encapsulating structure. In addition, the composition also incorporates one or more other, non-diffusing binder components that may be thermosetting or thermoplastic. The end result is an encapsulated structure with good hardness, durability, dimensional stability, resilience, and toughness.

Abstract: Novel parathyroid hormone (PTH) polypeptide derivatives are disclosed, as are pharmaceutical compositions containing said polypeptides, and synthetic and recombinant methods for producing said polypeptides. Also disclosed are methods for treating mammalian conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions containing said polypeptides. Also disclosed are methods for screening candidate compounds of the invention for antagonistic or agonistic effects on parathyroid hormone receptor action. Also disclosed are diagnostic and therapeutic methods of said compounds.

Abstract: Methods of fabricating optical elements that are encapsulated in monolithic matrices. The present invention is based, at least in one aspect, upon the concept of using multiphoton, multi-step photocuring to fabricate encapsulated optical element(s) within a body of a photopolymerizable composition. Imagewise, multi-photon polymerization techniques are used to form the optical element. The body surrounding the optical element is also photohardened by blanket irradiation and/or thermal curing to help form an encapsulating structure. In addition, the composition also incorporates one or more other, non-diffusing binder components that may be thermosetting or thermoplastic. The end result is an encapsulated structure with good hardness, durability, dimensional stability, resilience, and toughness.

Abstract: Synthetic and/or recombinant biologically active peptide derivatives of PTH(1-28), comprising a biologically active peptide at least 90% identical to a peptide consisting essentially of the formula: (a) X01ValSerGluIleGlnLeuMetHisAsn (SEQ ID NO:1); LeuGlyLysHisLeuAsnSerMetX02Arg ValGluTrpLeuArgLysLysLeu (b) fragments thereof containing amino acids 1-24, 1-25, 1-26, or 1-27; (c) pharmaceutically acceptable salts thereof; or (d) N- or C-derivatives thereof; wherein: X01 is Ser, Ala or Gly; and X02 is Glu or Arg, provided that said peptide is not hPTH(1-26)NH2, hPTH(1-27)NH2 or hPTH(1-28)NH2.

Abstract: A belt tensioner comprises first and second pulleys, a main arm and a sub-arm. The first pulley is displacable relative to an engine, and the second pulley is displacable relative to the first pulley. The main arm is connected to the first pulley, and a first spring is connected to the main arm and resists displacement of the first pulley when the engine is started. The sub-arm is connected to the second pulley, and a second spring is connected between the main arm and the sub-arm and maintains the second pulley generally equidistant from the first pulley while the engine is running.